who should avoid glp-1 medications 💊 not take them? ⚠️ Before starting treatment, it's important to understand safety considerations and whether GLP-1 therapy is right for your health profile. At HEALOR, we provide 💡Read the full guide here:

Estrogen or more precisely, the lack of it during menopause, when the ovaries dramatically reduce their output may impact how GLP-1s work

Heres where the evidence stands today, and what experts say you should think about before taking these types of medications

Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes

and Young, A

Ecnoglutide was independently developed by Sciwind Biosciences and is a newgeneration cAMPbiased GLP1 receptor agonist

Peer review Peer review information Nature Mental Health thanks Karolina Skibicka and the other, anonymous, reviewer(s) for their contribution to the peer review of this work